A phase II trial of gemcitabine (G), cisplatin (C), and nab-paclitaxel (N) in advanced biliary tract cancers (aBTCs).

被引：7
|
作者：
Shroff, Rachna T.
Borad, Mitesh J.
Xiao, Lianchun
Kaseb, Ahmed Omar
Varadhachary, Gauri R.
Wolff, Robert A.
Raghav, Kanwal Pratap Singh
Iwasaki, Michiko
Masci, Peter
Ramanathan, Ramesh K.
Ahn, Daniel H.
Bekaii-Saab, Tanios S.
Javle, Milind M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, GI Med Oncol Dept, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[6] Mayo Clin Arizona, Scottsdale, AZ USA
[7] Mayo Clin, Canc Ctr, Phoenix, AZ USA
[8] Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.4018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4018
引用
收藏
页数：5
相关论文
共 50 条
  • [1] A phase II trial of gemcitabine (G), cisplatin (C), and nab-paclitaxel (N) in advanced biliary tract cancers (aBTCs): Updated survival analysis.
    Shroff, Rachna T.
    Javle, Milind M.
    Xiao, Lianchun
    Kaseb, Ahmed Omar
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Raghav, Kanwal Pratap Singh
    Iwasaki, Michiko
    Masci, Peter
    Ramanathan, Ramesh K.
    Ahn, Daniel H.
    Bekaii-Saab, Tanios S.
    Borad, Mitesh J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [2] Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial
    Shroff, Rachna T.
    Javle, Milind M.
    Xiao, Lianchun
    Kaseb, Ahmed O.
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Raghav, Kanwal P. S.
    Iwasaki, Michiko
    Masci, Peter
    Ramanathan, Ramesh K.
    Ahn, Daniel H.
    Bekaii-Saab, Tanios S.
    Borad, Mitesh J.
    JAMA ONCOLOGY, 2019, 5 (06) : 824 - 830
  • [3] Gemcitabine, Cisplatin, and Nab-Paclitaxel as a First-Line Therapy for Advanced Biliary Tract Cancers
    Gedela, Sandeep
    Munot, Pritesh
    Vaidyanathan, Arvind
    Joarder, Ritam
    Chaugule, Deepali
    Parulekar, Manali
    Nashikkar, Chaitali
    Ghadi, Aayushi
    Vadodaria, Divya
    Goel, Mahesh
    Patkar, Shraddha
    Mandavkar, Sarika
    Ramaswamy, Anant
    Bhargava, Prabhat
    Srinivas, Sujay
    Ostwal, Vikas
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (01) : 263 - 269
  • [4] Gemcitabine, Cisplatin, and Nab-Paclitaxel as a First-Line Therapy for Advanced Biliary Tract Cancers
    Sandeep Gedela
    Pritesh Munot
    Arvind Vaidyanathan
    Ritam Joarder
    Deepali Chaugule
    Manali Parulekar
    Chaitali Nashikkar
    Aayushi Ghadi
    Divya Vadodaria
    Mahesh Goel
    Shraddha Patkar
    Sarika Mandavkar
    Anant Ramaswamy
    Prabhat Bhargava
    Sujay Srinivas
    Vikas Ostwal
    Journal of Gastrointestinal Cancer, 2024, 55 : 263 - 269
  • [5] SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.
    Shroff, Rachna T.
    Guthrie, Katherine A.
    Scott, Aaron James
    Borad, Mitesh J.
    Goff, Laura Williams
    Matin, Khalid
    Mahipal, Amit
    Kalyan, Aparna
    Javle, Milind M.
    Aghajanian, Carol
    Tan, Benjamin R.
    Cheema, Puneet S.
    Patel, Anuj K.
    Iyer, Renuka V.
    Kelley, Robin Kate
    Thumar, Jaykumar Ranchodbhai
    El-Khoueiry, Anthony B.
    Chiorean, E. Gabriela
    Hochster, Howard S.
    Philip, Philip Agop
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : LBA490 - LBA490
  • [6] SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
    Shroff, Rachna T.
    King, Gentry
    Colby, Sarah
    Scott, Aaron J.
    Borad, Mitesh J.
    Goff, Laura
    Matin, Khalid
    Mahipal, Amit
    Kalyan, Aparna
    Javle, Milind M.
    El Dika, Imane
    Tan, Benjamin
    Cheema, Puneet
    Patel, Anuj
    Iyer, Renuka
    Kelley, R. Katie
    Thumar, Jaykumar
    El-Khoueiry, Anthony
    Guthrie, Katherine A.
    Chiorean, E. Gabriela
    Hochster, Howard
    Philip, Philip A.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (05)
  • [7] Gemcitabine, Cisplatin, and nab-Paclitaxel for Patients With Advanced Biliary Tract Cancer: Closing the GAP
    Roth, Marc T.
    Goff, Laura W.
    JAMA ONCOLOGY, 2019, 5 (06) : 831 - 832
  • [8] A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer
    Liu, Ting
    Li, Qing
    Lin, Zhen
    Liu, Chunhua
    Pu, Wei
    Zeng, Shasha
    Lai, Jun
    Cai, Xuebin
    Zhang, Lisha
    Wang, Shuyang
    Chen, Miao
    Cao, Wei
    Gou, Hongfeng
    Zhu, Qing
    CANCER RESEARCH AND TREATMENT, 2024, 56 (02): : 602 - 615
  • [9] Genomic and transcriptomic biomarkers of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancer
    Woo, Seonjeong
    Kang, Beodeul
    Lee, Sung Hwan
    Kim, Jung Sun
    Kang, Haeyoun
    Yang, Seok Jeong
    An, Chansik
    Kim, Gwangil
    Hwang, Sohyun
    Kim, Chan
    Chon, Hong Jae
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer
    Pressiani, Tiziana
    Balsano, Rita
    Giordano, Laura
    Milella, Michele
    Bergamo, Francesca
    Bozzarelli, Silvia
    Noventa, Silvia
    Ferrrari, Daris
    Scartozzi, Mario
    Parra, Hector Soto
    Auriemma, Alessandra
    Solda, Caterina
    Zaniboni, Alberto
    Zecchetto, Camilla
    Rizzato, Mario Domenico
    Rimassa, Lorenza
    Santoro, Armando
    EUROPEAN JOURNAL OF CANCER, 2024, 207
12345